Deep-tech: 19 successful projects

VitaDX - SATT Paris-Saclay

VITADX

Diagnostics for life

VitaDX, created in 2015, is developing an innovative solution for the early detection of bladder cancer based on a patented technology which combines image processing and artificial intelligence.

CEO: Allan Rodriguez

Creation : april 2015

Headcount: 20

Location: Paris

Market(s): Health

www.vitadx.com

#AI #ImageProcessing #Diagnostic

TECHNO / PRODUCTS

VitaDX develops softwares with machine learning and deep learning algorithms to evaluate the morphological characteristics of cells in white light as well as metabolic variations in fluorescence in order to detect cancer very early on.

PRODUCTS PORTFOLIO

  • VisioCyt®

APPLICATIONS

VisioCyt® Diag, currently under development, is a software solution for the diagnosis of bladder cancer based on fluorescence imaging and artificial intelligence, using a simple urine sample.

BENEFITS

VisioCyt® is the only test, based on a patented method of analyzing cells present in urine in fluorescence and white light, coupled with artificial intelligence, to detect cellular alterations at an early stage of malignancy.

This automated and reproducible solution will significantly improve diagnostic performance compared to conventional practices while being in line with current clinical practice.

VitaDX
VitaDX

VITADX MINUTE